Icagen Reaffirms Recommendation to Shareholders to Tender Shares

Icagen ICGN announced today that it has sent the following letter to stockholders affirming the Board's recommendation after receiving a letter from Pfizer PFE on Friday, August 26, 2011 stating that Pfizer's best and final offer price is $6.00 per share:
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!